A Multicenter Prospective Randomized Study of Fully Covered Metallic Stent versus Tube Stent in Patients with Borderline Resectable Pancreatic Carcinoma

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2017
INTERVENTION: tube stent (more than 8.5 Fr) Fully covered metallic stent (more than 8 mm) CONDITION: Pancreatic carcinoma PRIMARY OUTCOME: Rate of cases who do not need stent exchange until surgical operation or diagnosis of inoperation INCLUSION CRITERIA: Borderline resectable Pancreatic ductal carcinoma case with bile duct stenosis (image diagnosis) Cases planed NAC(R)T more than 2 month PS(ECOG) 0 or 1 Adequate oral intake Estimated life expectancy more than 3 months Without another malignant disease With informed concent
Epistemonikos ID: 5e8afe288764c863ccf736cb69284136757dd5a1
First added on: Aug 23, 2024